The objective of the current study was to demonstrate the therapeutic potential of oral administration of glutathione in an open-label, single-arm, multicenter, pilot study prior to subsequent large-scale clinical trials
Experience the transformative effects of NAD combined with essential amino acids, promoting enhanced energy, cognitive function, and cellular rejuvenation
When studied together, the combination is investigated for its potential to generate a more complete and organised healing response than either peptide produces independently
Unlike traditional oral supplements, IV therapy bypasses the digestive system, allowing for immediate absorption and faster, more noticeable results
Scientific Classification A two-peptide blend combining a class B1 peptide-receptor ligand and a ghrelin-receptor ligand
The limited controlled trial data showed modest effects at best, which is a long way from establishing clinical usefulness